Choose a Membership Level
Arthrocart Biotech is a biotechnology startup, founded by Dr Michel Assor, orthopedic surgeon, from Marseille, France; with a patent for R&D of a cartilage and méniscal implant (scaffold), from double polymer and a human recombinant collagen expressed by tobacco, biocompatible and bio-absorbable, to treat grave knee arthritis, and to avoid knee arthroplasty in the young patient with good physical performance. The future of the arthritic treatment. Duration of the research: 4 years; from September 2020.
Help Arthrocart Biotech by sharing this page anywhere!
{{ tier.Description }}
We sent a verification code to: {{ emailSignup.email }}
Check your Gmail inbox.
If you don't get the email after a few minutes, tap below to resend.